Patient characteristics
high-grade glioma, tumor
TUMOR
Between April 2016 and June 2018, 26 patients with recurrent high-grade glioma after standard chemotherapy or radiotherapy were enrolled in the study and received intramuscular CGA injection (Demographic and baseline characteristics of the participating patients**All patients were Chinese.Randomization and treatment. The safety population included all patients who received at least one dose of chlorogenic acid. The population analyzed for response comprised all patients who received at least one cycle of chlorogenic acid and underwent tumor imaging (MRI).